PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 44 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,819,000 | +2254.0% | 685,687 | +938.6% | 0.01% | +1000.0% |
| Q3 2020 | $672,000 | -64.7% | 66,022 | -48.3% | 0.00% | -66.7% |
| Q2 2020 | $1,904,000 | +61.5% | 127,811 | +32.2% | 0.00% | 0.0% |
| Q1 2020 | $1,179,000 | +90.8% | 96,687 | +92.1% | 0.00% | +200.0% |
| Q3 2019 | $618,000 | -74.0% | 50,338 | -72.1% | 0.00% | -75.0% |
| Q2 2019 | $2,379,000 | – | 180,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|